AVR

4.9901.96%
CM

Chris Meduri

Chief Medical Officer & Member of Medical Advisory Board

Dr. Chris Meduri, M.D., P.H.P., serves as Chief Medical Officer at Anteris Technologies Ltd since September 1, 2021 and also serves as its Member of Medical Advisory Board. Dr. Meduri is a recognized leader in the field of valvular heart disease, serving as the national principle investigator of several valve trials and on numerous steering committees. He has performed first-in-US and first-in-world procedures, led enrollment in many trials and actively participated in 11 transcatheter early feasibility studies. Dr. Meduri completed his general, interventional and structural heart disease training at Beth Israel Deaconess Medical Center, Harvard Medical School. He completed his Masters in Public Health (MPH) with a focus on Clinical Effectiveness at the Harvard School of Public Health. He completed his internship and residency in Internal Medicine at Duke University.

Positions